<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04548479</url>
  </required_header>
  <id_info>
    <org_study_id>Incentive Spirometry vs PEP</org_study_id>
    <nct_id>NCT04548479</nct_id>
  </id_info>
  <brief_title>A Comparative Study of Incentive Spirometry and Positive Expiratory Pressure in Chest Trauma</brief_title>
  <official_title>A Comparative Study of Incentive Spirometry and Positive Expiratory Pressure in Patients With Chest Trauma: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital de Granollers</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital de Granollers</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chest trauma (CT) patients with 3 or more ribs fractures with or without pleuropulmonary&#xD;
      injury are an indicator of severity. Chest physiotherapy (CP) and analgesia is the first line&#xD;
      treatment in these patients.&#xD;
&#xD;
      The aim study is to evaluate the effect of positive expiratory pressure (PEP) breathing&#xD;
      compared to the incentive spirometry in terms of pain control in the recent phase of CT.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After acceptance to participate in the study, patients will be computerized randomized into 2&#xD;
      groups:&#xD;
&#xD;
        -  PEP group: positive expiratory pressure (PEP) breathing.&#xD;
&#xD;
        -  INS group: inspiratory incentive spirometry breathing. The period between day 0 and 20&#xD;
           days post-trauma is considered an immediate phase of TT.&#xD;
&#xD;
      Once admitted, an initial evaluation by the doctor will be performed, and pleuro-pulmonary&#xD;
      complications, the presence of respiratory failure, and pain control will be evaluated. The&#xD;
      CP will perform a clinical, pain control, secretion and a dynamic costal examination. The&#xD;
      medical treatment of pain control will begin, and the treatment of CP will begin, where it&#xD;
      will be randomized in 2 groups: 1- PEP group: positive expiratory pressure (PEP) breathing&#xD;
      the help of a PEP bottle device. 2- INS group: inspiratory incentive spirometry device&#xD;
      (Coach®). Will be daily FR sessions, on weekdays. Upon admission, hospital discharge and&#xD;
      post-discharge, radiological checks (simple radiography) will be performed and forced vital&#xD;
      capacity will be measured with forced spirometry.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 3, 2020</start_date>
  <completion_date type="Anticipated">February 2022</completion_date>
  <primary_completion_date type="Anticipated">February 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improve the degree of pain</measure>
    <time_frame>1 month</time_frame>
    <description>To assess if PEP decreased pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Resolution of pleural lesions</measure>
    <time_frame>1 month</time_frame>
    <description>To analysed if PEP allows faster resolution of pleural lesions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improve lung function</measure>
    <time_frame>1 month</time_frame>
    <description>To determined if PEP improves functional sequelae secondary to thoracic trauma.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduce hospital stay</measure>
    <time_frame>1 month</time_frame>
    <description>To assess if PEP decreased hospital stay</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Trauma Chest</condition>
  <arm_group>
    <arm_group_label>PEP group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Chest physiotherapy depending on the location of the ribs fractures techniques are performed: 1. Postural control techniques; 2. Airways clearance techniques; 3. Breathing exercise (diaphragmatic breathing). 4. Early mobilization. 5. Positive expiratory pressure (PEP) breathing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>INS group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Chest physiotherapy depending on the location of the ribs fractures techniques are performed: 1. Postural control techniques; 2. Airways clearance techniques; 3. Breathing exercise (diaphragmatic breathing). 4. Early mobilization. 5. Inspiratory incentive spirometry breathing</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PEP bottle</intervention_name>
    <description>PEP bottle: it will be performed with a bottle of distilled water and a plastic tube, where the patient breathes against a resistance during expiration.</description>
    <arm_group_label>PEP group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Chest trauma of 3 or more rib fractures with or without hemopneumothorax&#xD;
&#xD;
          -  Signed informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Non-collaborating patients.&#xD;
&#xD;
          -  Failure to submit a duly completed follow-up sheet for carrying out a minimum daily&#xD;
             guideline (3 times a day) for CP treatment.&#xD;
&#xD;
          -  Presence of respiratory failure at admission: PaO2 &lt;60mmHg and / or PaCO2&gt; 50mmHg.&#xD;
&#xD;
          -  Medical indication for invasive or non-invasive ventilatory support.&#xD;
&#xD;
          -  Presence of undrained pneumothorax.&#xD;
&#xD;
          -  Complications that limit early mobility.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>88 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gemma Molist</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital de Granollers</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Inmaculada Castillo</last_name>
    <phone>685225848</phone>
    <email>icastillo@fphag.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julia Tarrega</last_name>
    <email>jtarrega@fphag.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Inmaculada Castillo</name>
      <address>
        <city>Seva</city>
        <state>Barcelona</state>
        <zip>08553</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Inmaculada Castillo</last_name>
      <email>icastillo@fphag.org</email>
    </contact>
    <contact_backup>
      <last_name>Julia Tarrega</last_name>
      <email>jtarrega@fphag.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Overend TJ, Anderson CM, Lucy SD, Bhatia C, Jonsson BI, Timmermans C. The effect of incentive spirometry on postoperative pulmonary complications: a systematic review. Chest. 2001 Sep;120(3):971-8. Review.</citation>
    <PMID>11555536</PMID>
  </reference>
  <reference>
    <citation>Simon B, Ebert J, Bokhari F, Capella J, Emhoff T, Hayward T 3rd, Rodriguez A, Smith L; Eastern Association for the Surgery of Trauma. Management of pulmonary contusion and flail chest: an Eastern Association for the Surgery of Trauma practice management guideline. J Trauma Acute Care Surg. 2012 Nov;73(5 Suppl 4):S351-61. doi: 10.1097/TA.0b013e31827019fd.</citation>
    <PMID>23114493</PMID>
  </reference>
  <reference>
    <citation>Unsworth A, Curtis K, Asha SE. Treatments for blunt chest trauma and their impact on patient outcomes and health service delivery. Scand J Trauma Resusc Emerg Med. 2015 Feb 8;23:17. doi: 10.1186/s13049-015-0091-5. Review.</citation>
    <PMID>25887859</PMID>
  </reference>
  <reference>
    <citation>Gunduz M, Unlugenc H, Ozalevli M, Inanoglu K, Akman H. A comparative study of continuous positive airway pressure (CPAP) and intermittent positive pressure ventilation (IPPV) in patients with flail chest. Emerg Med J. 2005 May;22(5):325-9.</citation>
    <PMID>15843697</PMID>
  </reference>
  <reference>
    <citation>Sehlin M, Ohberg F, Johansson G, Winsö O. Physiological responses to positive expiratory pressure breathing: a comparison of the PEP bottle and the PEP mask. Respir Care. 2007 Aug;52(8):1000-5.</citation>
    <PMID>17650355</PMID>
  </reference>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>September 7, 2020</study_first_submitted>
  <study_first_submitted_qc>September 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 14, 2020</study_first_posted>
  <last_update_submitted>September 11, 2020</last_update_submitted>
  <last_update_submitted_qc>September 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Thoracic Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

